Folger Nolan Fleming Douglas Capital Management’s Medtronic MDT Stock Holding History

Folger Nolan Fleming Douglas Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Sell	3,256 -188	-5%	-$15.2K	0.02%	166
2026 Q1	$298K	Sell	3,444 -220	-6%	-$21.1K	0.03%	153
2025 Q4	$352K	Hold	3,664	–	–	0.04%	135
2025 Q3	$349K	Sell	3,664 -206	-5%	-$18.9K	0.04%	134
2025 Q2	$337K	Sell	3,870 -934	-19%	-$79.2K	0.04%	131
2025 Q1	$432K	Sell	4,804 -37	-0.8%	-$3.31K	0.05%	123
2024 Q4	$387K	Sell	4,841 -120	-2%	-$10.4K	0.04%	129
2024 Q3	$447K	Buy	4,961 +150	+3%	+$12.6K	0.04%	125
2024 Q2	$379K	Buy	4,811 +68	+1%	+$5.58K	0.04%	127
2024 Q1	$413K	Sell	4,743 -325	-6%	-$27.7K	0.04%	123
2023 Q4	$418K	Sell	5,068 -1,117	-18%	-$85.1K	0.05%	122
2023 Q3	$485K	Sell	6,185 -90	-1%	-$7.53K	0.06%	113
2023 Q2	$553K	Buy	6,275 +110	+2%	+$9.47K	0.06%	112
2023 Q1	$497K	Buy	6,165 +565	+10%	+$46K	0.06%	114
2022 Q4	$435K	Sell	5,600 -462	-8%	-$37.4K	0.05%	121
2022 Q3	$490K	Hold	6,062	–	–	0.07%	110
2022 Q2	$544K	Buy	6,062 +310	+5%	+$31.4K	0.07%	110
2022 Q1	$638K	Buy	5,752 +385	+7%	+$40.7K	0.07%	109
2021 Q4	$555K	Buy	5,367 +790	+17%	+$91.5K	0.06%	112
2021 Q3	$574K	Buy	4,577 +1,050	+30%	+$136K	0.07%	113
2021 Q2	$438K	Buy	3,527 +59	+2%	+$7.41K	0.05%	118
2021 Q1	$410K	Buy	3,468 +260	+8%	+$30.5K	0.05%	119
2020 Q4	$376K	Buy	3,208 +10	+0.3%	+$1.1K	0.05%	117
2020 Q3	$332K	Buy	3,198 +100	+3%	+$10K	0.05%	119
2020 Q2	$284K	Buy	3,098 +49	+2%	+$4.7K	0.05%	123
2020 Q1	$275K	Sell	3,049 -1,403	-32%	-$149K	0.05%	117
2019 Q4	$505K	Buy	4,452 +10	+0.2%	+$1.1K	0.07%	109
2019 Q3	$483K	Sell	4,442 -340	-7%	-$35.5K	0.07%	105
2019 Q2	$466K	Buy	4,782 +100	+2%	+$9.13K	0.07%	113
2019 Q1	$426K	Buy	4,682 +50	+1%	+$4.47K	0.06%	115
2018 Q4	$421K	Hold	4,632	–	–	0.07%	109
2018 Q3	$456K	Sell	4,632 -150	-3%	-$13.9K	0.06%	114
2018 Q2	$409K	Buy	4,782 +91	+2%	+$7.6K	0.06%	115
2018 Q1	$376K	Hold	4,691	–	–	0.06%	119
2017 Q4	$379K	Buy	4,691 +425	+10%	+$34K	0.05%	123
2017 Q3	$332K	Sell	4,266 -565	-12%	-$46.9K	0.05%	126
2017 Q2	$429K	Sell	4,831 -1,290	-21%	-$109K	0.07%	117
2017 Q1	$493K	Buy	6,121 +1,920	+46%	+$150K	0.07%	112
2016 Q4	$369K	Hold	4,201	–	–	0.06%	120
2016 Q3	$369K	Hold	4,201	–	–	0.06%	120
2016 Q2	$365K	Sell	4,201 -70	-2%	-$5.66K	0.06%	121
2016 Q1	$321K	Hold	4,271	–	–	0.06%	123
2015 Q4	$329K	Hold	4,271	–	–	0.06%	124
2015 Q3	$286K	Buy	+4,271	New	+$315K	0.06%	134

Other funds holding MDT

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

MAA

Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management's MDT Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management reduced its Medtronic (MDT) stake by 5.5% in Q2 2026, selling an estimated $15.2K and leaving 3,256 shares worth $255K. The position accounts for 0.02% of the portfolio, ranked #166.

Folger Nolan Fleming Douglas Capital Management first reported a position in MDT in Q3 2015 and has held it in 44 quarters since. The position peaked at $638K in Q1 2022. 534 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Folger Nolan Fleming Douglas Capital Management held 3,256 shares of Medtronic worth $255K as of Q2 2026.
Folger Nolan Fleming Douglas Capital Management sold 188 Medtronic shares in Q2 2026, an estimated $15.2K.
Medtronic made up 0.02% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #166 holding.
Folger Nolan Fleming Douglas Capital Management first reported a position in Medtronic in Q3 2015 and has held it in 44 quarters since.
Folger Nolan Fleming Douglas Capital Management's Medtronic position peaked at $638K in Q1 2022.
534 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.